These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6628806)

  • 21. Chronic active hepatitis associated with etretinate therapy.
    Weiss VC; Layden T; Spinowitz A; Buys CM; Nemchausky BA; West DP; Emmons KM
    Br J Dermatol; 1985 May; 112(5):591-7. PubMed ID: 4005158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily practice assessment of liver injury in patients with psoriasis on methotrexate.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2010 Jan; 162(1):211-3. PubMed ID: 19903179
    [No Abstract]   [Full Text] [Related]  

  • 23. Pulmonary and hepatic complications of methotrexate therapy of psoriasis.
    Filip DJ; Logue GL; Harle TS; Farrar WH
    JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate.
    Rosenbaum MM; Roenigk HH
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):357-61. PubMed ID: 6707259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver injury associated with methotrexate therapy for psoriasis.
    Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
    Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
    [No Abstract]   [Full Text] [Related]  

  • 26. Methotrexate induced liver disease in psoriasis.
    Millward-Sadler GH; Ryan TJ
    Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
    [No Abstract]   [Full Text] [Related]  

  • 27. Dangers of methotrexate/etretinate combination therapy.
    Zachariae H
    Lancet; 1988 Feb; 1(8582):422. PubMed ID: 2893228
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis.
    Glazer SD; Roenigk HH; Yokoo H; Sparberg M
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):683-7. PubMed ID: 7068976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of HLA antigen for methotrexate-induced liver damage in patients with psoriasis.
    Pestana A; Halprin KM; Taylor JR; Schiff ER; Esquenazi V; Comerford M; Gomez C
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):26-9. PubMed ID: 3980800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hazards of prolonged low-dose methotrexate therapy.
    Bender AS
    Va Med Mon (1918); 1970 Apr; 97(4):218-9. PubMed ID: 5317468
    [No Abstract]   [Full Text] [Related]  

  • 32. Concurrent use of methotrexate and acitretin revisited.
    Lowenthal KE; Horn PJ; Kalb RE
    J Dermatolog Treat; 2008; 19(1):22-6. PubMed ID: 18273721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral methotrexate therapy: pro and con].
    Zachariae H
    Hautarzt; 1985 Jan; 36(1):10-2. PubMed ID: 3972575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound as a screening procedure for methotrexate-induced hepatic damage in severe psoriasis.
    Miller JA; Dodd H; Rustin MH; Lees WR; Levene GM; Kirby JD; Munro DD
    Br J Dermatol; 1985 Dec; 113(6):699-705. PubMed ID: 3913457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatotoxic reactions in a patient treated with etretinate.
    Weiss VC; West DP; Ackerman R; Robinson LA
    Arch Dermatol; 1984 Jan; 120(1):104-6. PubMed ID: 6691707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].
    Ruszczak Z; Prószyńska-Kuczyńska W; Babiński S; Biernat S; Kulig A
    Przegl Dermatol; 1974; 61(6):803-7. PubMed ID: 4431967
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dynamics of some indices of interstitial metabolism in patients with psoriasis during treatment with methotrexate].
    Smelov NS; Lashmanova AP; Nikitina LV; Fedorovskaia RF; Makashev TK
    Vestn Dermatol Venerol; 1975 Nov; (11):8-13. PubMed ID: 1220384
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
    Halioua B; Saurat JH
    Br J Dermatol; 1990 Jun; 122 Suppl 36():135-50. PubMed ID: 2142437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum liver tests in patients treated with methotrexate. A retrospective analysis].
    Correa G H; Paredes S N
    Rev Med Chil; 2007 Aug; 135(8):1002-8. PubMed ID: 17989857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.